News Room

A collection of press releases, audio content and media clips featuring INFORMS members and their research.

AI Thinks Like Us – Flaws and All: New Study Finds ChatGPT Mirrors Human Decision Biases in Half the Tests
News Release

BALTIMORE, MD, April 1, 2025 – Can we really trust AI to make better decisions than humans? A new study says … not always. Researchers have discovered that OpenAI’s ChatGPT, one of the most advanced and popular AI models, makes the same kinds of decision-making mistakes as humans in some situations showing biases like overconfidence of hot-hand (gambler’s) fallacy yet acting inhuman in others (e.g., not suffering from base-rate neglect or sunk cost fallacies).

Read More
In 2025, you can’t have an effective democracy without data literacy
Media Coverage

You are swimming in an ocean of data and don’t even realize it. All around you are invisible amounts of data that would be staggering to try to comprehend. Thousands of smartphones and smart devices are talking to, sending and downloading vast amounts of data, video, audio, words, numbers, images, you name it. Everything from the latest movie on Netflix to someone’s radiology results from a cancer screening.

Read More
Shell Shocked: How Small Eateries Are Dealing With Record Egg Prices
Media Coverage

Mom-and-pop businesses are trying to adapt to the soaring cost of eggs. The owners of four egg-centric restaurants across the country show how they are coping with this threat to their livelihoods.

Read More

Resoundingly Human Podcast

An audio journey of how data and analytics save lives, save money and solve problems.

Media Contact

Ashley Smith
Public Affairs Coordinator
INFORMS
Catonsville, MD
[email protected]
443-757-3578

INFORMS in the News

What are you looking for?

Type of Content
Topic
Some States Are Racing Ahead of Others With Their Coronavirus Vaccine Rollouts. Their Secret? Keeping It Simple.

Some States Are Racing Ahead of Others With Their Coronavirus Vaccine Rollouts. Their Secret? Keeping It Simple.

The Washington Post, February 3, 2021

They all started in the same place, with no one immunized, no stockpiles of vaccine and no choice but to dive in immediately with perhaps the most high-stakes public health campaign in American history. Seven weeks later, the nation’s states are all racing to deliver a potentially lifesaving defense against the novel coronavirus to millions of arms. But some states are having far more success than others. In the states moving fastest, up to 1 in 7 people had received at least their first injection as of Wednesday, according to data compiled by The Washington Post. At the other end of the rankings, it was 1 in 17.

Pfizer Spent Months Working to Extract Sixth Dose From Vials as Vaccine Production Shortfalls Loomed

Pfizer Spent Months Working to Extract Sixth Dose From Vials as Vaccine Production Shortfalls Loomed

The Washington Post, February 3, 2021

Beginning in August, a half-dozen researchers at a Pfizer lab in Massachusetts sat down with vials of experimental coronavirus vaccine to learn how to transform the “overfill” in every vial — an extra amount of liquid that is standard for injectable pharmaceuticals — into a precious sixth dose. Over the next few months, they tested dozens of different combinations of syringes and needles, drawing out vaccine and squirting it into a beaker resting on a digital scale, repeating the experiments 5 to 10 times for each. By Jan. 6, the work paid off. Pfizer won approval from the Food and Drug Administration to say its vials contained six doses, instead of the five the agency had approved less than a month earlier with its Dec. 11 emergency authorization of the vaccine.

The US Government's $44 Million Vaccine Rollout Website Was a Predictable Mess - Here's How to Fix the Broken Process Behind ItTT

The US Government's $44 Million Vaccine Rollout Website Was a Predictable Mess - Here's How to Fix the Broken Process Behind ItTT

The Conversation, February 3, 2021

The COVID-19 vaccine rollout has been a nightmare for many Americans as they struggle through multi-step registration and appointment systems. The federal government had envisioned states using one national vaccine scheduling system, and it offered a contractor US$44 million to develop it. But that system turned out to be so poorly designed that all but nine states opted out before even trying to adopt it, even though it was being offered by the government for free. The few states that do use the Vaccine Administration Management System, or VAMS, have reported random appointment cancellations and unreliable registrations. Some vaccinators have had to resort to creating records on paper because of system glitches, slowing down the pace of getting shots into people’s arms.

Covid-19 Testing in Schools Bolsters Safety But is Hard to Set Up, Studies Find

Covid-19 Testing in Schools Bolsters Safety But is Hard to Set Up, Studies Find

The Wall Street Journal, February 4, 2021

Regularly testing for Covid-19 in K-12 schools can help identify cases and provide an extra layer of protection for staff and families, according to two reports commissioned by the Rockefeller Foundation released on Thursday. Implementing testing, however, is an enormous, logistically complex undertaking, and most schools need significant resources to make it feasible, the reports also found. One of the reports, conducted by research firm Mathematica, assessed programs in six pilot locations that either already have started or are planning to implement rapid antigen testing with the support of the Rockefeller Foundation, a philanthropic foundation that has focused on Covid-19 testing for much of the pandemic. Tests were provided by the Department of Health and Human Services.

Reasons to Not Take a COVID-19 Vaccine

Reasons to Not Take a COVID-19 Vaccine

Clarion News, February 4, 2021

Operation Warp Speed invested billions of taxpayer dollars to develop safe and effective vaccines to protect people against the worst outcomes from COVID-19. Under the Emergency Use Authorization (EUA), the pharmaceutical industry has delivered — in record time — two vaccines with the Food and Drug Administration (FDA) approval. Johnson & Johnson and Novavax have released promising efficacy data from their phase three clinical trials. Immunizing health care workers and those living in long-term care facilities was slower than expected, largely due to the logistics of getting people vaccinated. The vaccine supply chain is now beginning to show some structure, with the expectation that there will be ample supply and capacity to immunize everyone who wants to be immunized by the summer.  

Subject Matter Experts in

Supply Chain

View list of experts

Subject Matter Experts in

Healthcare

View list of experts

INFORMS Magazines

OR/MS Today is the INFORMS member magazine that shares the latest research and best practices in operations research, analytics and the management sciences.

Access OR/MS Today Magazine

Analytics magazine showcases articles and research reports based on big data, AI, machine learning, data analytics and other new-age technologies.

Access Analytics Magazine